A pharmaceutical company based in New Jersey

We are specializing in drug delivery technologies with a team of highly experienced professionals. Our management team members have over twenty-five years of experience on average in the pharmaceutical industry.
Read More
leaf1

ABOUT US

We are a pharmaceutical company specializing in drug delivery technologies with a team of highly experienced professionals. Our management team members have over twenty-five years of experience on average in the pharmaceutical industry.

Read More

OUR GOAL

Our goal and commitment is to bring quality products and reliable delivery to our valued customers.

Read More
tree

WHAT MAKES US SPECIAL

platform technology based

One of the primary objectives of Bostal is to enhance the performance of existing successful pharmaceutical products in and to be in the markets.

long-acting injectable (LAI) platform technologies

Zpheres® (microspheres), Geleepot® (in-situ gel), and Kriztols® (nanocrystals), we have been focusing on innovation of pharmaceutical preparations to serve various therapeutic areas including metabolic, CNS and oncology.

laboratories and commercial manufacturing facilities

We are equipped with state-of-the-art laboratories and commercial manufacturing facilities, and has passed multiple FDA, EU and other authorities’ GMP inspections.

OUR SERVICES

Our experienced R&D team with deep scientific expertise and practical know-how in multiple drug delivery technology platforms. We have a wide range of pharmaceutical processing technology and capability to meet various development and manufacturing needs, whether it is a new chemical entity or a well-established drug molecule.

service1
505(b)(2) Product 
Semaglutide LAI
service2
505(b)(2) Product 
Brexpiprazole LAI 1M
service3
Product Pipelines

WHY CHOOSE US

Our strong expertise in IP and technology assessment and experience with the FDA regulations and the U.S. generic pharmaceutical market also enables us to provide turn-key solutions to our international investors who want to enter into the U.S. generic market, from project evaluation to product development, bioequivalence evaluation, ANDA submission, commercial manufacturing and sales & marketing following ANDA approval.

1+
Projects Completed
1+
Total Employees
1%
Employess Master or Ph.d.
1+
R&D employees